3 research outputs found
The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry
Aim: We collected 'real-life' data on the management of patients with mastocytosis in the Italian Mastocytosis Registry. Methods: Six hundred patients diagnosed with mastocytosis between 1974 and 2014 were included from 19 centers. Results: Among adults (n = 401); 156 (38.9%) patients were diagnosed with systemic mastocytosis. In 212 adults, no bone marrow studies were performed resulting in a provisional diagnosis of mastocytosis of the skin. This diagnosis was most frequently established in nonhematologic centers. In total, 182/184 pediatric patients had cutaneous mastocytosis. We confirmed that in the most patients with systemic mastocytosis, serum tryptase levels were >20 ng/ml and KIT D816V was detectable. Conclusion: The Italian Mastocytosis Registry revealed some center-specific approaches for diagnosis and therapy. Epidemiological evidence on this condition is provided
Corrigendum: The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry (Future Oncology (2018) 14:26 (2713-2723) DOI: 10.2217/fon-2018-0291)
Following publication of the Research Article by SerenaMerante, Virginia V Ferretti, Chiara Elena, Valeria Brazzelli, Roberta Zanotti, Iria Neri, DiomiraMaglicane, Anna Belloni Fortina, Forer Ingeborg, Elide A Pastorello, Lisa Pieri, Cristina Papayannidis, Marina Mauro, Federica Grifoni, Roberto Minelli, Elena Guggiari, Elisa Difonzo, Monica Bocchia, Francesca Caroppo, Sergio DiNuzzo, ElenaMaria Elli,Michaela Rondoni, Rachele Ciccocioppo,Michele Di Stefano, Grazia Bossi, Emanuela Boveri, Patrizia Bonadonna, Fiorina Giona, Peter Valent &Massimo Triggiani, titled 'The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry', which appeared in the November 2018 issue of Future Oncology (Future Oncology [Lond.] 14[26], 2713-2723 [2018]; DOI: 10.2217/fon-2018-0291), it has been brought to our attention that the name of Iria Neri has been corrected as follows: The author name was originally published as Iria Ner, and has been corrected to Iria Neri. The authors and editors of Future Oncology would like to sincerely apologise for any confusion or inconvenience this may have caused our readers